Peptris Technologies news
Peptris Technologies appears in 2 stories we have published in August 2026, mostly in our Technology coverage. It is most often reported alongside Speciale Invest, Tenacity Ventures and BYT Ventures.
Latest development
Peptris uses AI to accelerate preclinical drug discovery in Bengaluru
Peptris Technologies, a Bengaluru-based startup, is applying artificial intelligence to preclinical drug discovery, targeting oncology, inflammation, and rare diseases. The company’s platform combines unsupervised learning, generative AI, and large language models to design and optimize drug candidates, aiming to reduce time and cost compared to traditional methods.
10 August 2026
Covered alongside
Peptris uses AI to accelerate preclinical drug discovery in Bengaluru
Peptris Technologies uses AI and machine learning to accelerate preclinical drug discovery for oncology, inflammation, and rare diseases in India.
Peptris Technologies secures ₹70 crore Series A for AI-led preclinical drug discovery
Peptris Technologies secures ₹70 crore in Series A funding to advance AI-led preclinical drug discovery. Lead asset PEPR-124 licensed to Revio Therapeutics.